Bone Biologics (BBLG) Retained Earnings (2010 - 2025)
Bone Biologics (BBLG) reported Retained Earnings of -$88.1 million for Q4 2025, down 3.66% year-over-year from -$91.5 million in Q4 2024, and down 0.84% quarter-over-quarter from -$87.4 million in Q3 2025.
Bone Biologics (BBLG) Retained Earnings (2010 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 16 years of Retained Earnings data on file, last reported at -$88.1 million in Q4 2025.
- Retained Earnings for Q4 2025 came in at -$88.1 million, down 3.66% year-over-year; the trailing twelve-month figure through Dec 2025 was -$88.1 million (down 3.66% YoY), and the FY2025 annual result was -$88.1 million, down 3.66% from the prior year.
- Retained Earnings retreated to -$88.1 million in Q4 2025 per BBLG's latest filing, from -$87.4 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$69.3 million in Q1 2021 and troughed at -$88.1 million in Q4 2025.
- A 5-year average of -$78.1 million and a median of -$78.4 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings dropped 2.11% in 2022, then decreased 12.44% in 2023.
- A 5-year view of Retained Earnings shows it stood at -$70.5 million in 2021, then decreased by 2.11% to -$72.0 million in 2022, then dropped by 12.44% to -$80.9 million in 2023, then dropped by 5.08% to -$85.0 million in 2024, then fell by 3.66% to -$88.1 million in 2025.
- Business Quant data shows BBLG's Retained Earnings at -$88.1 million in Q4 2025, -$87.4 million in Q3 2025, and -$86.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -838.07 Mn |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | -88.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -88.13 Mn |
| Sep 30, 2025 | -87.40 Mn |
| Jun 30, 2025 | -86.80 Mn |
| Mar 31, 2025 | -86.00 Mn |
| Dec 31, 2024 | -85.02 Mn |
| Sep 30, 2024 | -83.50 Mn |
| Jun 30, 2024 | -82.60 Mn |
| Mar 31, 2024 | -81.77 Mn |
| Dec 31, 2023 | -80.91 Mn |
| Sep 30, 2023 | -79.36 Mn |
| Jun 30, 2023 | -77.44 Mn |
| Mar 31, 2023 | -75.67 Mn |
| Dec 31, 2022 | -71.96 Mn |
| Sep 30, 2022 | -72.85 Mn |
| Jun 30, 2022 | -71.63 Mn |
| Mar 31, 2022 | -71.17 Mn |
| Dec 31, 2021 | -70.48 Mn |
| Sep 30, 2021 | -70.30 Mn |
| Jun 30, 2021 | -69.79 Mn |
| Mar 31, 2021 | -69.30 Mn |